Clinical Review

Stroke Risk

Author and Disclosure Information

 

References


COMPARING STROKE RISK SCORES FOR PATIENTS WITH AF
van den Ham HA, Klungel OH, Singer DE, et al. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J Am Coll Cardiol. 2015;66(17):1851-1859.

The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) risk score more accurately identified patients with atrial fibrillation (AF) who were at low risk for stroke than did the CHA2DS2-VASc score, which assigned the same patients to higher-risk categories, in a study of 60,594 patients with AF. Researchers found:
• Event rates for moderate- and high-risk categories for CHA2DS2-VASc were lower than those of the ATRIA and CHADS2.
• Age and previous stroke most strongly predicted ischemic stroke.
• C statistics for the full point scores were 0.70 for the ATRIA risk score, 0.68 for CHADS2, and 0.68 for CHA2DS2-VASc risk score.
• Net reclassification improvement was 0.23 for the ATRIA compared with CHA2DS2-VASc.
• Reclassifying patients with very low stroke risk and AF could prevent overuse of anticoagulants.

Continue for risk of thromboembolism after ICH: Is resumption of warfarin therapy safe? >>

Pages

Recommended Reading

Type 1 diabetes linked to excess weight gain before age 1
Type 2 Diabetes ICYMI
VIDEO: Early response predicts weight loss success with liraglutide
Type 2 Diabetes ICYMI
Poor pregnancy outcomes seen in teens with type 2 diabetes
Type 2 Diabetes ICYMI
VIDEO: Top hits from 2015 World Diabetes Congress
Type 2 Diabetes ICYMI
Partnering With Patients to Optimize Diabetes Therapy
Type 2 Diabetes ICYMI
Diabetes raises the cardiovascular risk higher in women than men
Type 2 Diabetes ICYMI
One-step gestational diabetes screen not beneficial
Type 2 Diabetes ICYMI
REPOSE: Mixed results for insulin pump vs. injections
Type 2 Diabetes ICYMI
REPOSE: Mixed Results for Insulin Pump vs Injections
Type 2 Diabetes ICYMI
Early-stage kidney disease benefits most from intensive glucose control
Type 2 Diabetes ICYMI

Related Articles